Subscribe to our newsletter and get the latest news and business opportunities in your inbox
EDF Renewables has inaugurated a 40 MWp solar project in Israel's Negev Desert and signed a power purchase agreement (PPA) with Teva Pharmaceutical to meet the power needs of the pharmaceutical giant based in Tel Aviv.
Teva will receive 100% renewable power to fuel its operations at all five locations across Israel, representing approximately 15% of the company's global power consumption. The 10-year PPA will officially commence in 2024.
The solar farm is a component of a larger project that integrates both photovoltaic (PV) and concentrating solar power (CSP) technologies. The electricity produced by this plant will be provided at a competitive tariff rate of ILS0.08 (equivalent to US$0.022) per kWh.
